Organization
Enliven Therapeutics
3 clinical trials
Clinical trial
A Phase 1a/1b Study of ELVN-002 Combined With Trastuzumab in Advanced Stage HER2+ Solid Tumors, and ELVN-002 Combined With Trastuzumab and Chemotherapy in Advanced Stage HER2+ Colorectal Cancer and Breast CancerStatus: Recruiting, Estimated PCD: 2027-01-01
Clinical trial
A Phase 1a/1b Study of ELVN-002 for the Treatment of Patients With HER2 Mutant Non-Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2026-12-01